Jessica J. Nielsen

Scheemda, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: April 30, 2026

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Journal: European journal of neurology

Published: March 19, 2026

Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.

Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 31, 2024

Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.

Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: November 04, 2024

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: June 29, 2023

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 27, 2022

The Journey towards resilience following a traumatic birth: A grounded theory.

The Journey towards resilience following a traumatic birth: A grounded theory.

Journal: Midwifery

Published: December 07, 2020

Development of a questionnaire to evaluate patients' awareness of cardiovascular disease risk in England's National Health Service Health Check preventive cardiovascular programme.

Development of a questionnaire to evaluate patients' awareness of cardiovascular disease risk in England's National Health Service Health Check preventive cardiovascular programme.

Journal: BMJ open

Published: September 27, 2017

Testing of a Model with Latino Patients That Explains the Links Among Patient-Perceived Provider Cultural Sensitivity, Language Preference, and Patient Treatment Adherence.

Testing of a Model with Latino Patients That Explains the Links Among Patient-Perceived Provider Cultural Sensitivity, Language Preference, and Patient Treatment Adherence.

Journal: Journal of racial and ethnic health disparities

Published: July 29, 2014

Factors affecting the motivation of healthcare professionals providing care to Emiratis with type 2 diabetes.

Factors affecting the motivation of healthcare professionals providing care to Emiratis with type 2 diabetes.

Journal: JRSM short reports

Published: March 12, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026